睿見教育(06068.HK)轉換股份及授予中國平安認沽期權議案遭小股東反對
睿見教育(06068.HK)宣布,於今日召開的股東特別大會上,就有關2018年6月與中國平安保險海外間接全資附屬公司PA Chokmah簽訂兩年期5億元貸款協議中債轉股部分,及授予PA Chokmah有關轉股後在指定期內可回售該等股份給大股東的認沽期權的關連交易議案進行表決。
經過獨立股東投票後,超過94%投票的小股東反對該決議案,因此睿見教育將不會進行轉換股份及授予中國平安認沽期權。
公司指,對於是次投票的獨立股東大比數反對該決議案,公司尊重獨立股東的意願,亦理解小股東的想法,此次債轉股折讓幅度較大,該決議案不獲通過符合小股東利益,避免造成潛在的股權稀釋影響,可消除市場對大幅折讓換股的擔憂。公司也向股東們表明,公司有足夠財務資源償還該筆貸款連同約定的退出費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.